ArticlePloS one2026
Common hemoglobin variants affecting the diagnosis of β-thalassemia: A large cohort data at a single center.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Elevated Hemoglobin AJournal of clinical laboratory analysis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany globin chain variants were interpreted as β-thalassemia or hereditary persistence of fetal hemoglobin (HPFH) at routine investigation. We described this in a large cohort of Thai subjects.
methodsHematological data of 43,414 subjects encountered at our thalassemia diagnostic center from January 2013 to July 2025 were reviewed. A total of 372 subjects with hemoglobin (Hb) variants were selectively recruited with leftover DNA specimens for further analysis. Hb analysis was done using high-performance liquid chromatography (HPLC) or capillary electrophoresis. β-globin gene mutations were identified using PCR and related techniques.
resultsAmong 372 subjects recruited, a total of 21 different Hb variants were found. The levels of Hb A2, Hb F, Hb variants, and DNA diagnostic requests were recorded. Hb variants with normal Hb A2 and Hb F levels were requested for β-thalassemia or HPFH in 12.3% (95% CI = 7.9-16.8). This error was increased in Hb variants with Hb A2 ≥ 3.6% [50.6% (95% CI = 39.8-61.4) and odds ratio of 7.3 (3.6-13.8)] and Hb F ≥ 5.0% [52.2% (95% CI = 37.7-66.6) and odds ratio of 7.8 (3.6-16.7)], especially in those with Hb A2 ≥ 3.6% and Hb F ≥ 5.0% [71.9% (95% CI = 56.3-87.5) and odds ratio of 18.2 (7.1-48.9)]. Hbs Hope, Tak, Cook, C, Lepore, and Q-Thailand were found to be associated with high proportions of the error.
conclusionsHb variants with increased Hb A2 levels and/or co-migration with Hb F are associated with a high proportion of mis-interpretation of β-thalassemia in routine practice. Combining Hb analysis using two different methods, and molecular analysis should help improve laboratory interpretation of the cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.